Ex Vivo Selection and Expansion of Cells Based on Expression of a Mutated Inosine Monophosphate Dehydrogenase 2 after HIV Vector Transduction: Effects on Lymphocytes, Monocytes, and CD34+ Stem Cells

This publication has 33 references indexed in Scilit:

• Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells
  The International Journal of Cell Cloning, 2009
• Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors
  Blood, 2004
• Expression profiling reveals off-target gene regulation by RNAi
  Nature Biotechnology, 2003
• Pharmacologically regulated in vivo selection in a large animal
  Blood, 2002
• Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells
  Molecular Therapy, 2002
• Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice
  International Journal of Cancer, 2002
• Protection and in Vivo Selection of Hematopoietic Stem Cells Using Temozolomide, O6-Benzylguanine, and an Alkyltransferase-Expressing Retroviral Vector
  Molecular Therapy, 2001
• Drug resistance gene transfer: Stem cell protection and therapeutic efficacy
  Experimental Hematology, 2000
• Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
  Science, 2000
• Characterization of the P140K, PVP(138-140)MLK, and G156A O⁶-Methylguanine-DNA Methyltransferase Mutants: Implications for Drug Resistance Gene Therapy
  Human Gene Therapy, 1999